Logan Capital Management’s Boston Scientific BSX Stock Holding History

Logan Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-125	Closed	-$12.6K	–	503
2025 Q1	$12.6K	Hold	125	–	–	﹤0.01%	386
2024 Q4	$11.2K	Hold	125	–	–	﹤0.01%	391
2024 Q3	$10.5K	Hold	125	–	–	﹤0.01%	398
2024 Q2	$9.63K	Hold	125	–	–	﹤0.01%	397
2024 Q1	$8.56K	Hold	125	–	–	﹤0.01%	402
2023 Q4	$7.23K	Hold	125	–	–	﹤0.01%	419
2023 Q3	$6.6K	Hold	125	–	–	﹤0.01%	418
2023 Q2	$6.76K	Hold	125	–	–	﹤0.01%	412
2023 Q1	$6.25K	Hold	125	–	–	﹤0.01%	428
2022 Q4	$5.78K	Hold	125	–	–	﹤0.01%	457
2022 Q3	$5K	Hold	125	–	–	﹤0.01%	445
2022 Q2	$5K	Hold	125	–	–	﹤0.01%	462
2022 Q1	$6K	Hold	125	–	–	﹤0.01%	462
2021 Q4	$5K	Hold	125	–	–	﹤0.01%	489
2021 Q3	$5K	Hold	125	–	–	﹤0.01%	482
2021 Q2	$5K	Hold	125	–	–	﹤0.01%	477
2021 Q1	$5K	Buy	+125	New	+$4.73K	﹤0.01%	452

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Logan Capital Management's BSX Position: Q2 2025 in Review

Logan Capital Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 125 shares — an estimated $12.6K sold.

Logan Capital Management first reported a position in BSX in Q1 2021 and held it in 17 quarters. The position peaked at $12.6K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Logan Capital Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Logan Capital Management sold 125 Boston Scientific shares in Q2 2025, an estimated $12.6K.
Logan Capital Management first reported a position in Boston Scientific in Q1 2021 and held it in 17 quarters.
Logan Capital Management's Boston Scientific position peaked at $12.6K in Q1 2025.
1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Logan Capital Management's 13F filing for Q2 2025, filed 1 Aug 2025.